Product Images Selexipag Titration Pack

This text provides information on the event-free rate of patients using Kaplan-Meier analysis. It includes the number of patients at risk, hazard ratio, confidence intervals, and logrank p-value for comparing two groups (Selexipag and Placebo) over time in months from randomization. The hazard ratio indicates the difference in event occurrence between the two groups. The results suggest that the Selexipag group had a lower event rate compared to the Placebo group.*

This seems to be a comparison of Selexipag versus Placebo over a period of 18 months. The data includes the number of patients at risk at different time points for each group. It appears that Selexipag had larger numbers of patients at risk compared to Placebo at certain time intervals. This information could be used for evaluating the effectiveness and safety of Selexipag compared to Placebo in a clinical trial.*

This is a table showing the estimated cumulative probability for the "at risk" group, with the number of instances at risk indicated as 10 and the cumulative probability reaching 574 at 101 instances.*

This text describes a medication template for Selexipag tablets containing 200 mcg. It includes essential information about the drug, dosage, storage instructions, manufacturer details, and a reminder to keep drugs out of the reach of children. It also mentions the NDC code and the need to read the prescribing information before use.*

This is a description of Selexipag Tablets, each tablet containing 600 mcg of selexipag. The text provides details on dosage, storage conditions, child-resistant packaging, manufacturer, and distributor information. It is advisable to read the prescribing information before use and store the tablets at a temperature between 20°C to 25°C (68°F to 77°F). The package is child-resistant, and it is important to keep all drugs out of the reach of children.*

This is a product information sheet for a medication called Selexipag. It is a film-coated tablet containing 800 mg of Selexipag. The usual dosage information is provided in the package insert, along with storage instructions at 20°C to 25°C. The packaging is child-resistant, and it should be kept in a tight container out of reach of children. The medication is manufactured by Zydus Lifesciences Ltd. in Ahmedabad, India, and distributed by Zydus Pharmaceuticals (USA) Inc. in Pennington, NJ.*

This is a description of a medication package containing selexipag tablets, each tablet with a strength of 1000 mcg. The package includes information on proper storage conditions and precautions to keep the medication out of reach of children. It also mentions the manufacturer as Zydus Lifesciences Ltd in Ahmedabad, India. The package contains 60 tablets and has a child-resistant seal. Dosage instructions are available in the package insert.*

This text provides information about Selexipag tablets, containing 1200 mcg per film-coated tablet. It includes dosage instructions, storage conditions, and safety precautions for keeping it out of the reach of children. The tablets are manufactured by 2ydus Lifesciences Ltd in Ahmedabad, India, and distributed by 2ydus Pharmaceuticals (USA) Inc. in Pennington, NJ.*

This text provides information about a medication called Selexipag in tablet form, with a dosage of 1400 mcg. The package contains 60 tablets and includes details on storage conditions, prescribing information, and manufacturer details. It also emphasizes the importance of keeping the medication out of reach of children.*

Description: This text provides information about a Lovs; Eodmg Template medication package containing Selexpag 1600 mg tablets. It includes details such as the NDC code, storage instructions, dosage information, and manufacturer details for Zydus Lifesciences Ltd. The package is child-resistant and should be kept away from children. This represents a prescription drug meant to be dispensed in a tight container.*

This text provides information about a Titration Pack containing Selexipag tablets in various dosages. It includes details such as the tablet quantities, recommended dosages, storage instructions, and a caution to keep the drugs out of reach of children. The pack contains 60 and 140 tablets, each coated with different Selexipag dosages, along with instructions on how to use the tablets properly. This Titration Pack is likely for medical use and requires attention to the prescribing information before use.*